EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer

Journal Title: Asian Pacific Journal of Tropical Medicine - Year 2018, Vol 11, Issue 4

Abstract

Objective: To explore the expression level and prognostic significance of erythropoietin receptor (EPOR) in patients with breast cancer (BRCA) based on estrogen receptor (ER) status and different molecular subtypes. Methods: The Cancer Genome Atlas (TCGA) and GTEx data were collected in GEPIA initially to identify the dysregulated genes. Further, bc- GenExMiner 4.1 online bioinformatics tool was used to evaluate EPOR mRNA differential expression level according to different classification of clinicopathologic parameters in patients with breast cancer. Additionally, the prognostic value between EPOR mRNA expression and free survival of metastatic relapse (MR) or any event (AE, namely any relapse or death) in patients with breast cancer was done. Results: EPOR mRNA was significantly downregulated in BRCA (1 085 cases) compared to normal tissues (291 cases) (P<0.05). Univariate Cox analysis revealed that high EPOR mRNA expression was remarkably correlated to a decreased risk of MR (HR: 0.79, P<0.000 1) and AE (HR: 0.87, P=0.000 7) especially in breast cancer patients with ER+. Besides, high EPOR mRNA level also associated with a favorable MRfree survival (HR: 0.81, P=0.007 2) and AE-free survival (HR: 0.88, P =0.029 9) in ER+ breast cancer patients. However, no similar above phenomenon was detected in ER- patients. Moreover, the subsequent prognostic adjusted analyses and univariate Cox analysis of AE based on SSP or SCM molecular subtypes validated the above results. Conclusion: EPOR mRNA level is a valuable prognostic indicator for patients with ER+ breast cancer.

Authors and Affiliations

Jing Pan, Yue-Yin Pan

Keywords

Related Articles

Zika virus infection and its emerging trends in Southeast Asia

Zika virus is a mosquito-borne flavivirus that represents a public health emergency at the ongoing epidemic. Previously, this rare virus was limited to sporadic cases in Africa and Asia until its emergence in Brazil, Sou...

Forecasting the number of zoonotic cutaneous leishmaniasis cases in south of Fars province, Iran using seasonal ARIMA time series method

Objective: To predict the trend of cutaneous leishmaniasis and assess the relationship between the disease trend and weather variables in south of Fars province using Seasonal Autoregressive Integrated Moving Average (SA...

Solvent–solvent fractionations of Combretum erythrophyllum (Burch.) leave extract: Studies of their antibacterial, antifungal, antioxidant and cytotoxicity potentials

Objective: To evaluate the biological activities of Combretum erythrophyllum (C. erythrophyllum) leaf extracts against infectious diseases' pathogenesis and their cytotoxicity potentials. Methods: Powdered leaf material...

Molecular identification of hemoplasmas in free ranging non-human primates in Thailand

Objective: To survey hemoplasmas infection in free ranging non-human primates from 8 provinces in Thailand. Methods: DNA from ethylenediaminetetraacetic acid blood of 262 free ranging non-human primates were identified a...

Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt

Objective To investigate molecular and serological prevalence of Toxoplasma gondii (T. gondii) in pregnant women and sheep in Egypt. Methods Blood samples collected from healthy 364 pregnant women and 170 sheep were in...

Download PDF file
  • EP ID EP283774
  • DOI 10.4103/1995-7645.231471
  • Views 53
  • Downloads 0

How To Cite

Jing Pan, Yue-Yin Pan (2018). EPOR mRNA level: A valuable prognostic indicator for patients with ER+ breast cancer. Asian Pacific Journal of Tropical Medicine, 11(4), 297-304. https://europub.co.uk/articles/-A-283774